Market Cap | ₹30,657Cr |
ROE | 25.39% |
P/E Ratio(TTM) | 32.96 |
EPS(TTM) | 74.44 |
P/B Ratio | 8.09 |
Dividend Yield | 1.14% |
Industry P/E | 35.18 |
Book Value | 303.37 |
Debt to Equity | 0.01 |
Face Value | 2 |
Parent Organisation | Ajanta Pharma Limited |
Managing Director | Mr. Rajesh Agrawal |
NSE Symbol | AJANTPHARM |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.69 | ||
Gland Pharma | NA (0.00%) | 41.16 | ||
Eris Lifesciences | NA (0.00%) | 52.58 | ||
Sai Life Sciences | NA (0.00%) | 75.63 |